Massachusetts Launches New Strengths-Based Early Psychosis Program

1
937

ServiceNet, a mental health and human service agency in western Massachusetts, received a three year, two million dollar grant to launch a program designed to support young adults who have recently experienced their first episode of psychosis. The Prevention and Recovery Early Psychosis (PREP) program is funded by the Massachusetts department of mental health and is designed to treat psychosis as a symptom, not an illness, resulting from other health problems, substance abuse, trauma, or extreme stress.

“Our expert team of clinical and support staff specialize in building on people’s strengths and interests to help them find happiness again and reconnect to their goals in life,” said Anne Hopkinson, PREP Program Director. “We see each program participant as a whole person on the path toward recovery, instead of as a patient with a lifelong illness.”

ServiceNet is headquartered in Northampton, MA and the PREP program will be run out of Holyoke. PREP is designed to treat young adults age 16-30 who are experiencing a break from reality where they may see, hear, or believe things that others cannot.

PREP professes to work from the assumption that “when a young person experiences a serious mental health crisis for the first time, surrounding him or her with needed therapy and support is the best way to prevent the condition from progressing.” To this end, PREP emphasizes the importance of healthy social relationships and provides individual, group, and family therapy, as well as job training and placement, substance abuse treatments, and traditional psychiatry.

Last month, the controversial and high-profile RAISE study reported on the superior outcomes of a similar treatment program, which focused more on therapy, support, and social connections than on high doses of antipsychotic drugs. While RAISE study authors purported to have used much lower than normal doses of antipsychotics, the data on this has not yet been forthcoming. Similarly, the PREP website indicates that “medication will not be part of every person’s road to recovery,” but that they “may be helpful in calming or dulling uncomfortable experiences.”

To learn more about the PREP program, click here →

 

Previous article“Psychiatry’s Mind-Brain Problem”
Next articlePrescription Privileges for Psychologists, Part II: Is Our Consent Fully Informed?
Justin Karter
Justin M. Karter, PhD, leads research news coverage and editorial strategy at Mad in America. He is the Acting Program Director of the PsyD in Clinical Psychology & Psychological Humanities at Boston College and part-time faculty with the Center for Psychological Humanities & Ethics. His scholarship examines historical and cultural formations of mind, subjectivity, and personhood; the roles of activist movements and lived-experience communities, including the consumer/survivor/ex-patient (C/S/X) tradition; and how mental health discourses shape institutions, practices, and identities. He works across mad studies, critical psychology, philosophy of psychology, and rights-based global mental health. Methodologically, he specializes in critical qualitative inquiry and psychotherapy process research grounded in intersubjective and phenomenological approaches. He is the President of APA Division 24 (2025-26) and serves on the Executive Board of Division 32. Previously, he was a Research Officer to the United Nations Special Rapporteur on the Right to Health. He earned his PhD in Counseling Psychology at the University of Massachusetts Boston, where his dissertation examined psychosocial disability advocacy in the global mental health movement. He also holds graduate degrees in Journalism and Community Psychology from Point Park University.

1 COMMENT

LEAVE A REPLY